日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Induction therapy with (177)Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients

采用 (177)Lu-DOTATATE 进行诱导治疗可使局部晚期或寡转移性胰腺神经内分泌肿瘤患者获得长期生存。

Minczeles, Noémie S; van Eijck, Casper H J; van Gils, Marjon J; van Velthuysen, Marie-Louise F; Nieveen van Dijkum, Els J M; Feelders, Richard A; de Herder, Wouter W; Brabander, Tessa; Hofland, Johannes

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome

肽受体放射性核素疗法(177Lu-DOTATATE)用于难治性类癌综合征的症状控制

Zandee, Wouter T; Brabander, Tessa; Blažević, Anela; Minczeles, Noémie S; Feelders, Richard A; de Herder, Wouter W; Hofland, Johannes

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

提高肽受体放射性核素治疗临床疗效的策略

Minczeles, N S; Hofland, J; de Herder, W W; Brabander, T